Fishelson Z - Search Results

1

Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.

Fishelson Z, Donin N, Zell S, Schultz S, Kirschfink M. Fishelson Z, et al. Mol Immunol. 2003 Sep;40(2-4):109-23. doi: 10.1016/s0161-5890(03)00112-3. Mol Immunol. 2003. PMID: 12914817 Review.

2

Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.

Gancz D, Donin N, Fishelson Z. Gancz D, et al. Among authors: fishelson z. Mol Immunol. 2009 Dec;47(2-3):310-7. doi: 10.1016/j.molimm.2009.09.016. Epub 2009 Oct 27. Mol Immunol. 2009. PMID: 19864026

3

Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention.

Fishelson Z, Kirschfink M. Fishelson Z, et al. Front Immunol. 2019 Apr 10;10:752. doi: 10.3389/fimmu.2019.00752. eCollection 2019. Front Immunol. 2019. PMID: 31024572 Free PMC article. Review.

4

Cell signals transduced by complement.

Bohana-Kashtan O, Ziporen L, Donin N, Kraus S, Fishelson Z. Bohana-Kashtan O, et al. Among authors: fishelson z. Mol Immunol. 2004 Jul;41(6-7):583-97. doi: 10.1016/j.molimm.2004.04.007. Mol Immunol. 2004. PMID: 15219997 Review.

5

Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid.

Donin N, Jurianz K, Ziporen L, Schultz S, Kirschfink M, Fishelson Z. Donin N, et al. Among authors: fishelson z. Clin Exp Immunol. 2003 Feb;131(2):254-63. doi: 10.1046/j.1365-2249.2003.02066.x. Clin Exp Immunol. 2003. PMID: 12562385 Free PMC article.

6

Programmed necrotic cell death induced by complement involves a Bid-dependent pathway.

Ziporen L, Donin N, Shmushkovich T, Gross A, Fishelson Z. Ziporen L, et al. Among authors: fishelson z. J Immunol. 2009 Jan 1;182(1):515-21. doi: 10.4049/jimmunol.182.1.515. J Immunol. 2009. PMID: 19109183

7

Receptor-Interacting Protein Kinases 1 and 3, and Mixed Lineage Kinase Domain-Like Protein Are Activated by Sublytic Complement and Participate in Complement-Dependent Cytotoxicity.

Lusthaus M, Mazkereth N, Donin N, Fishelson Z. Lusthaus M, et al. Among authors: fishelson z. Front Immunol. 2018 Feb 23;9:306. doi: 10.3389/fimmu.2018.00306. eCollection 2018. Front Immunol. 2018. PMID: 29527209 Free PMC article.

8

Complement resistance of tumor cells: basal and induced mechanisms.

Jurianz K, Ziegler S, Garcia-Schüler H, Kraus S, Bohana-Kashtan O, Fishelson Z, Kirschfink M. Jurianz K, et al. Among authors: fishelson z. Mol Immunol. 1999 Sep-Oct;36(13-14):929-39. doi: 10.1016/s0161-5890(99)00115-7. Mol Immunol. 1999. PMID: 10698347 Review.

9

K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement.

Jurianz K, Ziegler S, Donin N, Reiter Y, Fishelson Z, Kirschfink M. Jurianz K, et al. Among authors: fishelson z. Int J Cancer. 2001 Sep;93(6):848-54. doi: 10.1002/ijc.1406. Int J Cancer. 2001. PMID: 11519047

10

Complement and apoptosis.

Fishelson Z, Attali G, Mevorach D. Fishelson Z, et al. Mol Immunol. 2001 Aug;38(2-3):207-19. doi: 10.1016/s0161-5890(01)00055-4. Mol Immunol. 2001. PMID: 11532282 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters